Hormonal
In women, sleeping 8 hours is associated with significantly lower Interleukin-6 (IL-6) levels compared to sleeping 7 hours, suggesting an optimal sleep window for this specific inflammatory marker.
For women, extending sleep from 7 to 8 hours may help lower IL-6, a key inflammatory marker. While 7 hours is often cited as standard, this data suggests 8 hours might be the sweet spot for inflammation control in women, whereas men showed no such benefit.
However, a consistent observation was that those individuals who slept 8 hours per night, as compared with those who slept 7 hours, had significantly lower levels of IL-6 (P < 0.05).
Why this rating
Statistically significant in multiple adjusted models, but the overall linear/nonlinear trend was not significant, making it a specific contrast rather than a general rule.
Source
Gender Differences in the Cross-Sectional Relationships Between Sleep Duration and Markers of inflammation: Whitehall II Study
Michelle A. Miller et al. · SLEEP · 2009
DOI 10.1093/sleep/32.7.857
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →